HomeAI NewsOpenAI Offers Free ChatGPT Access for Clinicians

OpenAI Offers Free ChatGPT Access for Clinicians

U.S. healthcare professionals can now utilize the AI model for clinical care, documentation, and research without charge.

OpenAI has made its ChatGPT model available for free to verified U.S. physicians, nurse practitioners, and pharmacists. This move supports clinical care, documentation, and research by providing a tool that can assist with tasks such as patient education and medical literature review.

The benefits of using ChatGPT in healthcare settings include improved accuracy, increased efficiency, and enhanced patient outcomes. By leveraging the model’s capabilities, clinicians can focus on high-value tasks while delegating routine or time-consuming activities to AI.

OpenAI’s decision to offer free access to ChatGPT for U.S. healthcare professionals is part of its broader efforts to expand the use of its technology in various industries. The company has been actively working with healthcare organizations and researchers to explore applications of its models and technologies in m…

The availability of ChatGPT for clinicians is not limited to clinical care alone. The model can also be used for research purposes, enabling healthcare professionals to conduct literature reviews, identify relevant studies, and develop new insights more efficiently.

What matters

  • Verified U.S. physicians, nurse practitioners, and pharmacists are eligible for free access to ChatGPT.
  • OpenAI aims to support clinical care, documentation, and research by providing a tool that can assist with tasks such…
  • The move is part of OpenAI’s efforts to expand the use of its AI technology in healthcare settings.

Why it matters

The move is part of OpenAI’s efforts to expand the use of its AI technology in healthcare settings.

This GenAI News article was prepared in original wording using reporting and materials published by OpenAI News. Source reference: https://openai.com/index/making-chatgpt-better-for-clinicians.

Drafted by the GenAI News review pipeline.

latest articles

explore more